We examined the expression of CDK2 rising immunohistochemistry in 102 cases
of laryngeal squamous cell carcinomas (LSCCs). The results showed that a t
otal of 63.73% (65/102) patients revealed a CDK2 overexpression pattern and
the CDK2 overexpression was correlated significantly with the tumor site,
tumor size and advanced stage. A positive correlation between the CDK2 expr
ession and proliferative activity of tumor cells measured by proliferating
cell nuclear antigen was found (I = 0.894, p < 0.0001). The Kaplan-Meier's
analysis skewed that shorter disease-free survival was significantly associ
ated with tumor grade, tumor size, lymph node metastasis and advanced stage
. Overall survival was significantly associated with tumor grade, tumor siz
e, lymph node metastasis, advanced stage and CDK2 overexpression. When CDK2
and PCNA were combined, the patients with both CDK2 overexpression and PCN
A overexpression had a poorer overall survival. We concluded that the CDK2
overexpression may be associated with the malignant biological behaviour of
LSCCs.